LACTOLOGY FOUNDATION

Contact laxatives in ATC class A06AB are stimulant agents that act locally on the colonic mucosa to increase peristalsis and promote defecation, and they can generally be used during lactation with appropriate caution, short-term dosing, and preference for non‑stimulant alternatives when feasible.medpedia.framar+2

Pharmacological class and agents

A06AB (contact laxatives) belongs to the ATC main group A “Alimentary tract and metabolism” and the subgroup A06 “Drugs for constipation”.wikipedia+1
Contact laxatives are also termed stimulant laxatives, reflecting their ability to trigger colonic motor activity and fluid secretion.naver+1

The class includes the following active substances and combinations:atccode+2

·        Oxyphenisatine (A06AB01)

·        Bisacodyl (A06AB02)

·        Dantron (A06AB03)

·        Phenolphthalein (A06AB04)

·        Castor oil (A06AB05)

·        Senna glycosides (A06AB06)

·        Cascara (A06AB07)

·        Sodium picosulfate (A06AB08)

·        Bisoxatin (A06AB09)

·        Contact laxatives in combination (A06AB20, A06AB30, A06AB52, A06AB53, A06AB56, A06AB57, A06AB58).atcddd.fhi+2

Contact laxatives are indicated for short‑term relief of constipation and sometimes as part of bowel preparation regimens before diagnostic or surgical procedures.webmd+2

Mechanism of action and general toxicology

Contact laxatives act primarily on the colon by direct or indirect irritation of the mucosa and enteric nerve plexuses.webmd+3
This stimulation increases peristaltic contractions and often enhances secretion of water and electrolytes into the lumen, leading to accelerated transit and softer stools.medpedia.framar+2

Typical onset of action is within 6–12 hours after oral dosing and 15–60 minutes after rectal administration for drugs such as bisacodyl.webmd+1
Because of their stimulatory effect, these agents can cause abdominal cramping, urgency and diarrhea and may provoke complete evacuation of bowel contents.breastfeedingnetwork+3

Acute overdose can result in severe diarrhea, fluid and electrolyte loss and, in extreme cases, dehydration and hypotension, especially in vulnerable patients.webmd+1
Chronic or excessive use is associated with risk of laxative dependence, impaired colonic motility, melanosis coli (for anthraquinone derivatives), and possible hepatic injury described with long‑term senna use.breastfeedingnetwork+1

Lactation safety – class overview

Most laxatives, including many contact agents, are either poorly absorbed from the maternal gastrointestinal tract or extensively metabolised, resulting in negligible transfer into breast milk.sps+1
Professional guidance states that any laxative can be used during breastfeeding when needed, but recommends bulk‑forming or osmotic laxatives as first choice and stimulants only for occasional short‑term use.gpnotebook+2

Stimulant laxatives (senna, bisacodyl, sodium picosulfate) are accepted for intermittent use in breastfeeding mothers provided the lowest effective dose is used for the shortest duration.sps+1
Available clinical data indicate that senna compounds taken by nursing women do not alter infant stool patterns, suggesting minimal or clinically irrelevant exposure through milk.pmc.ncbi.nlm.nih+1

For all A06AB agents in lactation, good practice is to avoid chronic daily use, monitor maternal stool pattern and hydration, and observe the breastfed infant for diarrhea, unusual fussiness or poor weight gain, particularly in neonates and preterm infants.gpnotebook+2

Toxicological–lactational profile by key agents

Bisacodyl (A06AB02) and combinations

Bisacodyl is a diphenylmethane stimulant laxative that increases colonic motility and promotes water accumulation in stools, with typical oral onset within 6–12 hours and faster effect from suppositories.webmd
It is poorly absorbed and largely converted locally in the intestine to an active metabolite, with minimal systemic exposure and negligible presence in breast milk.droracle+1

Specialist breastfeeding sources state that bisacodyl can be used during breastfeeding and is considered safe in full‑term healthy infants when used intermittently.droracle+2
Recommended precautions include using the lowest effective dose, avoiding therapy beyond about one week without medical review, and monitoring the infant for diarrhea or irritability.gpnotebook+2

Senna glycosides (A06AB06) and combinations

Senna glycosides (sennosides) are anthraquinone derivatives that exert a laxative effect by irritating the colonic mucosa and stimulating peristalsis.webmd
Randomised clinical observation in nursing mothers receiving senna preparations showed effective maternal relief from constipation without measurable impact on infant bowel habits.pmc.ncbi.nlm.nih

Senna is described as possibly safe during breastfeeding for up to one week, with only small quantities of active principles crossing into breast milk.webmd
Toxicological concerns focus on prolonged use: high doses or treatment beyond one week may cause dependence, electrolyte disturbances and potential liver injury in the mother, so chronic therapy in lactating women is discouraged.webmd

Sodium picosulfate (A06AB08) and combinations

Sodium picosulfate is another diphenylmethane stimulant laxative, structurally related to bisacodyl, that is activated by colonic bacteria and acts locally on mucosal nerves.naver+2
It is used for occasional constipation and in higher doses for bowel cleansing, with rapid stimulant effect and recognized risk of diarrhea and electrolyte imbalance if misused.breastfeedingnetwork

Breastfeeding references list sodium picosulfate among stimulant laxatives suitable for occasional use in nursing mothers, with low expected milk transfer because of limited systemic absorption.sps+1
Short‑term administration at standard doses appears compatible with breastfeeding, but infants should be observed for loose stools when the maternal dose is substantial or part of bowel‑prep regimens.sps+1

Castor oil (A06AB05)

Castor oil contains ricinoleic acid, which stimulates intestinal peristalsis and can induce strong evacuations and cramping.medpedia.framar+1
It is generally reserved for short‑term use because of its intense and unpredictable laxative effect and potential for dehydration in the mother if overused.naver

Data on castor oil and breastfeeding are limited, but systemic absorption of ricinoleic acid is modest and significant passage into breast milk is unlikely.gpnotebook+1
Given its potent stimulant profile, castor oil is not usually recommended as first‑line in lactating women; if used, it should be a single‑dose intervention with careful monitoring of both mother and infant.breastfeedingnetwork+2

Anthraquinone botanicals (cascara, senna) and others

Cascara and other anthraquinone‑containing botanicals share the stimulant mechanism and toxicological features of senna, including risk of dependence and melanosis coli with chronic intake.naver+1
Lactational safety is extrapolated from senna data: short‑term, low‑dose use is acceptable, whereas long‑term daily use is discouraged in breastfeeding mothers.pmc.ncbi.nlm.nih+2

Legacy agents such as oxyphenisatine, phenolphthalein and bisoxatin are now less frequently used due to safety concerns or availability issues, but they remain within A06AB and share stimulant laxative toxicity patterns.gelbe-liste+1
In lactating women, these older stimulants should preferably be avoided when better‑studied alternatives (bisacodyl, senna, sodium picosulfate) are available, especially given historic concerns about carcinogenicity and other adverse effects with some compounds.gelbe-liste+1

Clinical use and risk minimisation in breastfeeding

Guidelines on laxative use during breastfeeding emphasise non‑pharmacological measures (dietary fibre, hydration, physical activity) as first‑line interventions.breastfeedingnetwork
When medication is required, osmotic or bulk‑forming laxatives are preferred initial choices, with stimulant (contact) laxatives reserved for occasional adjunctive use or when other options fail.sps+2

For A06AB medicines in nursing mothers:

·        Use the lowest effective dose for the shortest duration, ideally not exceeding a few days without review.webmd+3

·        Avoid chronic daily stimulant laxative use to prevent maternal dependence and bowel dysfunction.breastfeedingnetwork+1

·        Prefer agents with better breastfeeding data (bisacodyl, senna, sodium picosulfate) when a stimulant is necessary.droracle+3

·        Monitor the infant for diarrhea, poor weight gain or unusual irritability, particularly in neonates and preterm infants.gpnotebook+2

Overall, contact laxatives in A06AB can be considered lactation‑compatible when used intermittently and judiciously, embedded in a broader constipation management plan that prioritises lifestyle measures and safer non‑stimulant pharmacologic options.sps+2